US Stock Volatility: Johnson & Johnson Plunges on October 13 Due to Pressure on Medical Device Business and Talcum Powder Lawsuit Costs
Bitget异动解读2026/10/13 14:06Johnson & Johnson October 13 Drop Explained
Keywords: Pressure on device business, talcum powder litigation costs
1. The third-quarter results announced on October 13 showed that several segments of the medical technology business underperformed expectations, with overall operational growth at 6%, below analysts' expectations of 7.4%; surgical revenue declined and the performance of the medical device business dragged down overall results.
2. The results announced on October 13 included a one-time charge related to the proposed resolution of talcum powder litigation, causing third-quarter diluted earnings per share to fall to $0.09, a significant year-on-year decline; although adjusted earnings per share beat expectations and full-year guidance was raised, reported profit remains under clear pressure.
(Disclaimer: This content is generated by AI technology based on publicly available information for reference only and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Renowned analyst revises outlook: Tech giants' capital expenditures to peak in 2027, cash shortages may be exposed earlier
Ives predicts that tech giants' capital expenditures will peak in 2027, free cash flow will bottom out in the first half of next year, and a cash flow inflection point will be reached in 2029.
Euro advances on ECB rate hike expectations, weaker US Dollar
Crypto prices
More
